Evidence map›Paper›PMID 42058316›Full record

ArticleIDCases2026

Severe acute respiratory distress syndrome associated with human metapneumovirus infection in a morbidly obese adult.

Nanami Sugai, Wataru Iwanaga

Abstract readCase Reports
In one paragraph

Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nanami SugaiDepartment of Emergency and Critical Care Medicine, Urasoe General Hospital, 1-56-1 Maeda, Urasoe, Okinawa 901-2102, Japan.
Wataru IwanagaDepartment of Emergency and Critical Care Medicine, Urasoe General Hospital, 1-56-1 Maeda, Urasoe, Okinawa 901-2102, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human metapneumovirus (hMPV) is a recognized cause of respiratory tract infections and can occasionally lead to severe pneumonia and acute respiratory distress syndrome (ARDS) in adults. However, reports describing the clinical course and management of hMPV-associated ARDS in adults remain limited. We report a case of severe ARDS caused by hMPV infection in a morbidly obese adult who achieved a favorable outcome with standard ARDS management. A 58-year-old man with morbid obesity (body mass index 36.6 kg/m²) was admitted to a previous hospital with fever and cough. Due to rapidly progressive hypoxemia, he was transferred to our hospital. On arrival, he exhibited severe hypoxemia (PaO₂/FiO₂ ratio of 90 mmHg) and was diagnosed with severe ARDS based on the global definition of ARDS, requiring invasive mechanical ventilation. Respiratory multiplex polymerase chain reaction testing identified hMPV on hospital day (HD) 2, and systemic corticosteroid therapy was discontinued because bacterial infection was considered unlikely. Standard ARDS management, including a low tidal volume strategy and prone positioning under neuromuscular blockade, resulted in rapid improvement in oxygenation. The patient was extubated on HD 5 and subsequently managed with high-flow nasal cannula oxygen therapy and noninvasive positive pressure ventilation. He was discharged on HD 11 without supplemental oxygen. This case highlights that hMPV infection can cause severe ARDS in morbidly obese adults and underscores the importance of early etiological diagnosis using respiratory multiplex PCR testing, as well as appropriate implementation of standard ARDS management, even in severe ARDS.

Indexed as

Acute respiratory distress syndromeHuman metapneumovirusMorbid obesityMultiplex polymerase chain reactionProne positioningViral pneumonia

Identifiers

PMID42058316
PMCPMC13123484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.